Literature DB >> 8571364

Physiologically based pharmacokinetic/pharmacodynamic modeling of chemical mixtures and possible applications in risk assessment.

H A el-Masri1, R S Thomas, S A Benjamin, R S Yang.   

Abstract

Human exposure to chemicals, be it environmental or occupational, is rarely, if ever, limited to a single chemical. Therefore, it is essential that we consider multiple chemical effects and interactions in our risk assessment process. However, with the almost infinitely large number of chemical mixtures in the environment, systematic studies of the toxicology of these chemical mixtures with conventional methodologies and approaches are impossible because of the immense resources and unrealistically long durations required. Thus, the development of predictive and alternative toxicology method is imperative. In order to have a reasonable chance to deal with the complex issue of toxicology of chemical mixtures, we believe that the following concepts must be considered: (1) the exploitation of recent advances in computational technology; (2) the utilization of mathematical/statistical modeling; (3) coupling computer modeling with very focused, mechanistically based, and short-term toxicology studies. Our approach is, therefore, the utilization of physiologically based pharmacokinetic/pharmacodynamic (PB-PK/PD) modeling, coupled with very focused, model-directed toxicology experiments as well as other statistical/mathematical modeling such as isobolographic analysis and response surface methodology. Tissue dosimetry at the pharmacokinetic and pharmacodynamic levels is achievable with simple and complex, but chemically defined, mixtures. Our long-term goal is to formulate innovative risk assessment methodologies for chemical mixtures. In this presentation, one of our specific research projects is described: PB-PK/PD modeling of toxicologic interactions between Kepone and carbon tetrachloride (CCl4) and the coupling of Monte Carlo simulation for the prediction of acute toxicity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8571364     DOI: 10.1016/0300-483x(95)03222-2

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  6 in total

Review 1.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Use of probabilistic modeling within a physiologically based pharmacokinetic model to predict sulfamethazine residue withdrawal times in edible tissues in swine.

Authors:  Jennifer Buur; Ronald Baynes; Geof Smith; Jim Riviere
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

Review 3.  Evaluating quantitative formulas for dose-response assessment of chemical mixtures.

Authors:  Richard C Hertzberg; Linda K Teuschler
Journal:  Environ Health Perspect       Date:  2002-12       Impact factor: 9.031

Review 4.  Toxicology of chemical mixtures: international perspective.

Authors:  V J Feron; F R Cassee; J P Groten
Journal:  Environ Health Perspect       Date:  1998-12       Impact factor: 9.031

5.  A Model-Based Framework to Identify Optimal Administration Protocols for Immunotherapies in Castration-Resistance Prostate Cancer.

Authors:  Roberta Coletti; Andrea Pugliese; Andrea Lunardi; Orazio Caffo; Luca Marchetti
Journal:  Cancers (Basel)       Date:  2021-12-28       Impact factor: 6.639

6.  Pharmacokinetic-pharmacodynamic model of newly developed dexibuprofen sustained release formulations.

Authors:  Selvadurai Muralidharan
Journal:  ISRN Pharm       Date:  2012-12-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.